Mission

"Help raise awareness and provide funding for the research of rare kidney cancers like HLRCC in children and young adults." “I am personally experiencing the effects of rare kidney cancer (HLRCC) and I have seen the effects on others who are also being treated. More research is needed to help them and their families so institutions (like National Cancer Institute at NIH, Yale Smilow Cancer Center, Georgetown Lombardi Cancer Center, and David Geffen School of Medicine at UCLA) can continue to help those who suffer from rare kidney cancers. With this continued collaboration from these institutions, we are growing closer to new cures.” -Andrew Lee Founder, Driven To Cure INC, www.driventocure.org